Bacillus spp - other than B. cereus group

(> 70 species)
Related species include Cytobacillus spp, Lysinibacillus spp, Paenibacillus spp, Peribacillus spp

 

Gram Stain

  • Gram positive large spore forming bacilli (aerobic/facultative)

Clinical Significance

These organisms are widely distributed in nature, especially soil environments. Their spores may contaminate dried foods (spices/tea/flour/powders).

These organisms are low level pathogens that typically represent environmental contamination of cultures.

They have rarely been associated with septicemia, endocarditis, brain abscesses, peritonitis, wound and ocular infections typically in immunocompromised patients.

Some species can cause diarrheal illness.

 

Usual Susceptibility Pattern

Non–cereus group Bacillus species are typically susceptible to ampicillin, penicillin, ceftriaxone, imipenem, clindamycin, macrolides, vancomycin (rare resistance reported), linezolid, and aminoglycosides.

 

Lysinibacillus and Paenibacillus spp- Many strains are resistant to penicillin/ampicillin. Susceptibility to ceftriaxone, clindamycin, macrolides, tetracyclines , quinolones, vancomycin and TMP-SMX is variable. Most are susceptible to linezolid.


Daptomycin MICs are often elevated – possibly due to resistance in spores with reversion to susceptibility on germination.

 

Empiric Therapy
Clinically Significant Infection:

Penicillin

Lysinibacillus and Paenibacillus - vancomycin or linezolid